FIELD: medicine, pediatrics, immunology. SUBSTANCE: method involves an enteral administration of the preparation that is a kefir yeast polysaccharide, by 2-5 doses being each dose has 200 mg of the preparation, 2-3 times per 24 h for 10-12 days. Method ensures to enhance the effectiveness of therapy and provides the enhancement of nonspecific anti-infectious resistance of children body. EFFECT: enhanced effectiveness of therapy, decreased adverse responses. 3 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF ENTERIC INFECTION PROPHYLAXIS | 1994 |
|
RU2097050C1 |
METHOD FOR TREATMENT OF GASTROENTEROCOLITIS | 1994 |
|
RU2099072C1 |
METHOD OF TREATMENT OF CHILDREN WITH INFECTIOUS MONONUCLEOSIS | 1998 |
|
RU2150955C1 |
METHOD OF TREATMENT OF CHILDREN WITH PNEUMOCYSTIC INFECTION | 1995 |
|
RU2122861C1 |
METHOD OF TREATMENT OF CHILDREN OF FIRST YEAR LIFE WITH ACUTE RESPIRATORY VIRAL DISEASE | 2001 |
|
RU2195315C2 |
METHOD OF PERTUSSIS TREATMENT IN CHILDREN | 1997 |
|
RU2145872C1 |
METHOD FOR TREATING MYASTHENIA | 2001 |
|
RU2193892C2 |
METHOD OF VIRAL DIARRHEA TREATMENT | 1994 |
|
RU2104030C1 |
METHOD OF TREATMENT OF PATIENTS WITH DIPHTHERIA TOXIC FORMS | 1996 |
|
RU2137497C1 |
METHOD FOR EVALUATING THERAPEUTIC EFFICIENCY IN CASE OF GASTRODUODENAL DISEASES IN CHILDREN | 2001 |
|
RU2197737C1 |
Authors
Dates
2002-07-27—Published
1999-05-14—Filed